Wout A. Van Den Broek
Nieuwegein, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
2025 Acute Coronary Syndrome Guideline: Missing the Boat on CYP2C19 Genotyping.
Journal: Journal of the American Heart Association
Published: May 06, 2026
Lipid-lowering therapy omission at discharge and one-year outcomes after percutaneous coronary intervention: a real-world analysis of overall and elderly patients.
Journal: International journal of cardiology. Heart & vasculature
Published: April 22, 2026
Genotype-Guided P2Y12-Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI.
Journal: Circulation. Cardiovascular interventions
Published: February 26, 2026
Genotype-Guided P2Y12-Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI.
Journal: Circulation. Cardiovascular interventions
Published: February 26, 2026
Sex differences in the presentation and management of acute coronary syndrome patients: Insights from the FORCE-ACS registry.
Journal: International journal of cardiology. Heart & vasculature
Published: October 09, 2025
Genotype-Guided vs Conventional Oral P2Y12 Inhibitors in Acute Coronary Syndrome: A Combined Analysis of TAILOR-PCI and POPular Genetics.
Journal: JACC. Cardiovascular interventions
Published: July 31, 2025
Treatment Modifications in Acute Coronary Syndrome Patients Treated with Ticagrelor: Insights from the FORCE-ACS Registry.
Journal: Thrombosis and haemostasis
Published: October 29, 2024
Cost-effectiveness of implementing a genotype-guided de-escalation strategy in patients with acute coronary syndrome.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: September 17, 2024
The puzzle of antiplatelet therapy in ACS: ticagrelor monotherapy is another missing piece.
Journal: European heart journal
Published: July 26, 2024
Temporary omission of oral anticoagulation in atrial fibrillation patients undergoing percutaneous coronary intervention: rationale and design of the WOEST-3 randomised trial.
Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: July 15, 2024
Genotype-Guided Antiplatelet Therapy: JACC Review Topic of the Week.
Journal: Journal of the American College of Cardiology
Published: May 30, 2024
P2Y12 Inhibition in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention: The SWAP-AC-2 Study.
Journal: JACC. Cardiovascular interventions
Published: February 26, 2024
Last Updated: 09/26/2026